FDA Drug Application (050698) for BIAXIN by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number050698
Product Number001
FormFOR SUSPENSION;ORAL
Dosage125MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBIAXIN
Active IngredientCLARITHROMYCIN

Active IngredientCount
List of drugs with Active Ingredient CLARITHROMYCIN6


Back to FDA Applications sponsored by ABBVIE